News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EMD Biosciences, Inc. Releases New Web-Based Signal Transduction Interactive Pathways


10/19/2005 5:11:49 PM

EMD Biosciences, Inc. (EMD), a major supplier of premium tools for proteomics and disease pathway analysis known through its global brands Calbiochem(R), Novabiochem(R), and Novagen(R), today announced the release of several new Signal Transduction Interactive Pathways on its website. EMD is part of the Life Science and Analytics (LSA) division of Merck KGaA (Darmstadt, Germany) and operates as EMD Biosciences, Inc. in North America and as Merck Biosciences outside North America.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES